CWG
PTLA

C WorldWide Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

C WorldWide Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-334,366
Closed -$2.38M – 90
2020
Q1 		$2.38M Hold
334,366
– – 0.03% 65
2019
Q4 		$7.99M Hold
334,366
– – 0.1% 55
2019
Q3 		$8.97M Hold
334,366
– – 0.11% 51
2019
Q2 		$9.07M Buy
334,366
+175,000
+110% +$5.49M 0.11% 53
2019
Q1 		$5.53M Hold
159,366
– – 0.07% 52
2018
Q4 		$3.11M Sell
159,366
-64,316
-29% -$1.32M 0.05% 62
2018
Q3 		$5.96M Buy
223,682
+76,095
+52% +$2.48M 0.08% 57
2018
Q2 		$5.57M Buy
147,587
+54,988
+59% +$2.1M 0.08% 60
2018
Q1 		$3.02M Sell
92,599
-12,072
-12% -$530K 0.05% 71
2017
Q4 		$5.09M Sell
104,671
-18,130
-15% -$917K 0.07% 56
2017
Q3 		$6.63M Buy
122,801
+26,211
+27% +$1.54M 0.09% 56
2017
Q2 		$5.42M Sell
96,590
-27,963
-22% -$1.12M 0.08% 60
2017
Q1 		$4.88M Buy
124,553
+10,373
+9% +$330K 0.08% 54
2016
Q4 		$2.56M Sell
114,180
-11,933
-9% -$233K 0.05% 74
2016
Q3 		$2.86M Buy
126,113
+74,600
+145% +$1.75M 0.05% 76
2016
Q2 		$1.22M Hold
51,513
– – 0.02% 91
2016
Q1 		$1.05M Hold
51,513
– – 0.02% 99
2015
Q4 		$2.65M Sell
51,513
-25,500
-33% -$1.24M 0.05% 74
2015
Q3 		$3.28M Hold
77,013
– – 0.06% 69
2015
Q2 		$3.51M Buy
77,013
+15,000
+24% +$603K 0.05% 76
2015
Q1 		$2.35M Buy
62,013
+25,000
+68% +$859K 0.03% 79
2014
Q4 		$1.05M Sell
37,013
-15,919
-30% -$443K 0.02% 87
2014
Q3 		$1.36M Buy
+52,932
New +$1.39M 0.02% 87

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

C WorldWide Group's PTLA Position: Q2 2020 in Review

C WorldWide Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 334,366 shares — an estimated $2.38M sold.

C WorldWide Group first reported a position in PTLA in Q3 2014 and held it in 23 quarters. The position peaked at $9.07M in Q2 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • C WorldWide Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • C WorldWide Group sold 334,366 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $2.38M.
  • C WorldWide Group first reported a position in Portola Pharmaceuticals, Inc. in Q3 2014 and held it in 23 quarters.
  • C WorldWide Group's Portola Pharmaceuticals, Inc. position peaked at $9.07M in Q2 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on C WorldWide Group's 13F filing for Q2 2020, filed 5 Aug 2020.